Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
The Pharmacogenomics Journal|February 28, 2007
Low frequency of CYP2D6 poor metabolizers among schizophrenia patientsA Llerena, P Dorado, E M Peñas-Lledó, et al.
The Pharmacogenomics Journal|April 13, 2016
High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from ArgentinaG Moya, P Dorado, V Ferreiro, et al.
Veterinary and Animal Science|October 12, 2023
Microencapsulated essential oils influence the growth and foregut histomorphometry of Nile tilapia (Oreochromis niloticus) fingerlingsJesús Roldan-Juarez, Rubén Pinares, Carlos E Smith, et al.
The Pharmacogenomics Journal|October 30, 2003
CYP2C9 gene and susceptibility to major depressive disorderA LLerena, R Berecz, P Dorado, et al.
Revista De Enfermeria (Barcelona, Spain)|May 8, 2000
[Subcutaneous drug administration. Indications for the use in terminal patients]S Postigo Mota, A Llerena Ruiz, J M Lavado García, et al.
British Journal of Clinical Pharmacology|November 1, 1995
Patterns of drug treatment of schizophrenic patients in Estonia, Spain and SwedenR A Kiivet, A Llerena, M L Dahl, et al.
Pageof 9